Here are six highlights:
1. Dr. Bruder gave a presentation titled, “Our Journey from Autologous to Allogeneic Stem Cell Therapy: How did we get here & when do we use what?”
2. He delivered the presentation with Timothy Ganey, PhD, Lou Barnes and Lisa Ferrara, PhD.
3. Dr. Bruder commented the presentation focused on the “translation and commercialization for the present and future of stem cell medicine.”
4. In its 12th year, the World Stem Cell Summit offers 225 speakers and more than 90 hours of programming, attracting more than 1,200 attendees.
5. Heading New York City-based Bruder Consulting International, Dr. Bruder offers services to medical device, biotechnology and regenerative medicine clients.
6. In his role as Amendia chairman, Dr. Bruder assists in developing biologic implants and medical devices for spine.
More articles on devices:
Global orthopedic devices market to hit $47.5B by 2022 — 3 highlights
Computer-assisted surgical systems market report — North America dominates
InVivo to highlight TrailMaker for SCI patients at tissue engineering & regenerative conference: 5 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
